Activation of NFκB is essential but not sufficient to stimulate mitogenesis of vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 235, Issue 2, 1997, Pages 365-368

  Bretschneider, Ellen ^b   Wittpoth, Michael ^b   Weber, Artur Aron ^b   Glusa, Erika ^b   Schrör, Karsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PENTOXIFYLLINE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; AMASTATIN; ANTIINFECTIVE AGENT; PEPTIDE; PEPTIDE FRAGMENT; PROTEINASE INHIBITOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE (P508 530); THROMBIN RECEPTOR-ACTIVATING PEPTIDE (P508-530); THYMIDINE; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; CATTLE; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; AMINO ACID SEQUENCE; ANIMAL; ARTERY; CELL CULTURE; CELL DIVISION; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; MOLECULAR GENETICS; WESTERN BLOTTING;

ANIMALIA; BOS TAURUS; BOVINAE;

ACETYLCYSTEINE; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ARTERIES; BLOTTING, WESTERN; CATTLE; CELL DIVISION; CELLS, CULTURED; CORONARY VESSELS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PENTOXIFYLLINE; PEPTIDE FRAGMENTS; PEPTIDES; PROTEASE INHIBITORS; THROMBIN; THYMIDINE; VASODILATOR AGENTS;

EID: 0031577096     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6788     Document Type: Article

References (17)

1. 1. Sen, R., and Baltimore, D. (1986) Cell 47, 921-928.
2. 2. Nabel, G., and Baltimore, D. (1987) Nature 326, 711-713.
3. 3. Visvanathan, K. V., and Goodbourn, S. (1989) EMBO J. 8, 1129-1138.
4. 4. La Rosa, F., Pierce, J., and Sonenshein. G. E. (1993) Mol. Cell. Biol. 14, 1039-1045.
5. 5. Ji, L., Arcinas, M., and Boxer, L. (1994) Mol. Cell. Biol. 14, 7967-7977.
6. 6. Bellas, R. E., Lee, J. S., and Sonenshein, G. E. (1995) J. Clin. Invest. 696, 2521-2527.
7. 7. Autieri, M. V., Yue, T.-L., Ferstein, G. Z., and Ohlstein, E. (1995) Biochem. Biophys. Res. Comm. 213, 827-836.
8. 8. Nakajima, T., Kitajima, I., Shin, H., Takasaki, I., Shigeta, K., Abeyama, K., Yamashita, Y., Tokioka, T., Soejima, Y., and Maruyama, I. (1994) Biochem. Biophys. Res. Comm. 204, 950-955.
9. 9. Vu, T.-K., Hung, D. T., Wheaton, V. I., Coughlin, S. R. (1991) Cell 64, 1057-1068.
10. 10. McNamara, C. A., Sarembock, I. J., Gimple, L. W., Fenton, J. W. II, Coughlin, S. R., and Owens, G. K., (1993) J. Clin. Invest. 91, 94-98.
11. 11. Grand, R. J. A., Turnell, A. S., and Grabham, P. W. (1996) Biochem. J. 313, 353-368.
12. 12. Großer, T., Zucker, T.-P., Weber, A.-A., Schulte, K., Sachinidis, A., Vetter, H., and Schrör, K. (1997) Eur. J. Pharmacol. 319, 327-332.
13. 13. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Nucl. Acid. Res. 11, 1475-1489.
14. 14. Bradford, M. (1976) Anal. Biochem. 72, 248-254.
15. 15. Herbért, J. M., Lamarche, I., and Dol, F. (1992) FEBS Lett. 301, 155-158.
16. 16. Kanthou, C., Benzakour, O., Patel, G., Deadman, J., Kakkar, V. V., and Lupu, F. (1995) Thromb. Haemost. 74, 1340-1347.
17. 17. McNamara, C. A., Sarembock, I. J., Gimple, L. W., Fenton, I. I., and Owens, G. K. (1995) Drug Develop. Res. 35, 7-12.